In addition, although this was a small‐sample analysis, this is the first study to have assessed immune‐suppressive cells of human venous blood samples in advanced NSCLC patients treated with chemotherapy including a VEGF inhibitor. The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.